CIPLA

Completes Acquisition of Inzpera Healthsciences

has completed the acquisition of 100% stake in Inzpera Healthsciences on December 04, 2025, making Inzpera a wholly owned subsidiary of the company. This acquisition marks a strategic step to integrate Inzpera’s wide portfolio of paediatric pharmaceutical and wellness products with Cipla’s robust distribution network and operational strengths, enabling greater scale, market reach, and growth potential. Earlier, Cipla had entered into definitive agreements to acquire the entire stake in Inzpera. Cipla is a global pharmaceutical company committed to delivering high-quality, technologically advanced healthcare solutions to meet everyday patient needs.